Alternative funding models for medical innovation: the role of product development partnerships in product innovation for infectious diseases

Dimitrios Kourouklis, Mikel Berdud (), Mireia Jofre-Bonet and Adrian Towse
Additional contact information
Dimitrios Kourouklis: CERNA i3 - Centre d'économie industrielle i3 - Mines Paris - PSL (École nationale supérieure des mines de Paris) - PSL - Université Paris Sciences et Lettres - I3 - Institut interdisciplinaire de l’innovation - CNRS - Centre National de la Recherche Scientifique

Post-Print from HAL

Date: 2022-06-28
References: Add references at CitEc
Citations:

Published in Applied Economics Letters, 2022, pp.1-5. ⟨10.1080/13504851.2022.2095335⟩

There are no downloads for this item, see the EconPapers FAQ for hints about obtaining it.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:hal:journl:hal-03710938

DOI: 10.1080/13504851.2022.2095335

Access Statistics for this paper

More papers in Post-Print from HAL
Bibliographic data for series maintained by CCSD ().